- Record: found
- Abstract: not found
- Article: not found
Elamipretide, a mitochondria-targeted drug, for the treatment of vision loss in dry AMD with noncentral geographic atrophy: results of the Phase 1 ReCLAIM Study
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.